Detalles de la búsqueda
1.
Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats.
Biol Pharm Bull
; 47(3): 669-679, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38508765
2.
Osteogenic Effects of KY-054, a Novel Coumarin Derivative on Femur Cortical Bone in Ovariectomized Female Rats.
Biol Pharm Bull
; 46(10): 1435-1443, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779045
3.
Synthesis and Evaluation of Novel Triaryl Derivatives with Readthrough-Inducing Activity.
Chem Pharm Bull (Tokyo)
; 71(9): 701-716, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37661376
4.
Discovery of Novel Chromenopyridine Derivatives as Readthrough-Inducing Drugs.
Chem Pharm Bull (Tokyo)
; 71(12): 859-878, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38044139
5.
Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats.
Biol Pharm Bull
; 44(5): 659-668, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33952822
6.
Synthesis and Evaluation of a Novel Series of 2,7-Substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Selective Peroxisome Proliferator-Activated Receptor γ Partial Agonists.
Chem Pharm Bull (Tokyo)
; 69(4): 333-351, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33790079
7.
(S)-1,2,3,4-Tetrahydroisoquinoline Derivatives Substituted with an Acidic Group at the 6-Position as a Selective Peroxisome Proliferator-Activated Receptor γ Partial Agonist.
Chem Pharm Bull (Tokyo)
; 67(11): 1211-1224, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31685749
8.
Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.
J Pharmacol Sci
; 137(1): 38-46, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29731242
9.
2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
Chem Pharm Bull (Tokyo)
; 66(12): 1131-1152, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30504630
10.
Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive Actions.
Chem Pharm Bull (Tokyo)
; 65(12): 1144-1160, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29199219
11.
Novel 2,7-Substituted (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids: Peroxisome Proliferator-Activated Receptor γ Partial Agonists with Protein-Tyrosine Phosphatase 1B Inhibition.
Chem Pharm Bull (Tokyo)
; 63(12): 998-1014, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26633022
12.
Insulin sensitization by a novel partial peroxisome proliferator-activated receptor γ agonist with protein tyrosine phosphatase 1B inhibitory activity in experimental osteoporotic rats.
J Pharmacol Sci
; 124(2): 276-85, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24553405
13.
Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition.
Bioorg Med Chem
; 20(2): 1060-75, 2012 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22197396
14.
The role of CDK8 in mesenchymal stem cells in controlling osteoclastogenesis and bone homeostasis.
Stem Cell Reports
; 17(7): 1576-1588, 2022 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35777359
15.
A novel series of (S)-2,7-substituted-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor α/γ dual agonists with protein-tyrosine phosphatase 1B inhibitory activity.
Chem Pharm Bull (Tokyo)
; 59(10): 1233-42, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21963632
16.
2-Acyl-tetrahydroisoquinoline-3-carboxylic acids: lead compounds with triple actions, peroxisome proliferator-activated receptor α/γ agonist and protein-tyrosine phosphatase 1B inhibitory activities.
Chem Pharm Bull (Tokyo)
; 59(7): 876-9, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21720040
17.
CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
Oncogene
; 40(15): 2803-2815, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33727660
18.
Novel acyl-CoA: cholesterol acyltransferase inhibitor: indoline-based sulfamide derivatives with low lipophilicity and protein binding ratio.
Chem Pharm Bull (Tokyo)
; 58(8): 1057-65, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20686260
19.
Novel tetrahydroisoquinoline derivatives with inhibitory activities against acyl-CoA: cholesterol acyltransferase and lipid peroxidation.
Chem Pharm Bull (Tokyo)
; 58(8): 1066-76, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20686261
20.
Novel indoline-based acyl-CoA: cholesterol acyltransferase inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities.
Bioorg Med Chem
; 17(16): 6020-31, 2009 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19608421